(Q43174427)

English

The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse

scientific article published on 4 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 November 2017

The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse (English)

1 reference

Europe PubMed Central

15 November 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Kjeld Schmiegelow

1

object named as

K Schmiegelow

1 reference

Europe PubMed Central

15 November 2017

author name string

M Heyman

2

1 reference

Europe PubMed Central

15 November 2017

G Gustafsson

3

1 reference

Europe PubMed Central

15 November 2017

B Lausen

4

1 reference

Europe PubMed Central

15 November 2017

F Wesenberg

5

1 reference

Europe PubMed Central

15 November 2017

J Kristinsson

6

1 reference

Europe PubMed Central

15 November 2017

K Vettenranta

7

1 reference

Europe PubMed Central

15 November 2017

H Schroeder

8

1 reference

Europe PubMed Central

15 November 2017

E Forestier

9

1 reference

Europe PubMed Central

15 November 2017

S Rosthoej

10

1 reference

Europe PubMed Central

15 November 2017

Nordic Society of Paediatric Haematology and Oncology (NOPHO)

11

1 reference

Europe PubMed Central

15 November 2017

publication date

4 February 2010

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

24

1 reference

Europe PubMed Central

15 November 2017

4

1 reference

Europe PubMed Central

15 November 2017

715-720

1 reference

Europe PubMed Central

15 November 2017

https://scigraph.springernature.com/pub.10.1038/leu.2009.303

0 references

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Age- and sex-specific incidence of childhood leukemia by immunophenotype in the Nordic countries

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

A rapid, radiochemical-ligand binding assay for methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Effect of dose intensity and therapy-induced leukocytopenia in intensive therapy on the prognosis of acute lymphatic leukemia in childhood. Results in 213 patients of the COALL-85 study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Relapse in acute lymphoblastic leukemia as a function of white blood cell and absolute neutrophil counts during maintenance chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Physician compliance and relapse rates of acute lymphoblastic leukemia in children.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Profile of non-compliance in lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Compliance with oral chemotherapy in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Developmental pharmacology--drug disposition, action, and therapy in infants and children

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

6-Thioguanine in children with acute lymphoblastic leukaemia: influence of food on parent drug pharmacokinetics and 6-thioguanine nucleotide concentrations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

21 January 2018

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of 6-mercaptopurine, 6-thioguanine nucleotides, and 6-thiouric acid in biological fluids by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

White-cell counts in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Relapse factors during maintenance therapy of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.303

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2009.303

1 reference

Europe PubMed Central

15 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43174427&oldid=1982867297"